This proposal describes experiments that will further our understanding of transcriptional control and oncogenesis caused by the Rel family of proteins and proteins that associate with Rel proteins. Although the primary focus is on the vRel retroviral oncoprotein, other Rel (cRel, NF- kappaB p50/p105, p49/p100, etc.) and IkappaB-like proteins (p40, MAD-3, etc.) will also be characterized. Most studies will be performed with avian proteins, since the avian system is still the only system in which frank transformation of cells by Rel proteins has been seen. Our long- range goal is an understanding of the mechanism by which Rel proteins control normal and abnormal cell growth. As such, there are several related Specific Aims. First, using approaches that have previously been successful for us, we will isolate additional avian rel-related cDNAs. For example, we will clone a chicken p49/p100 cDNA. Using this cDNA, we will determine whether p100 is the remaining unidentified vRel-associated protein. We will characterize vRel protein complexes in vitro and in vivo. Using Gal4 fusion proteins, in vitro mutagenesis, and genetic selections in yeast, we will characterize sequences important for transcriptional activation in Rel and IkappaB proteins. In addition, we will attempt to identify the proteins with which these activation domains interact in chicken cells and in yeast. We will determine the effect of phosphorylation on chicken cRel, specifically in terms of regulation of subcellular location, DNA binding and dimerization. Finally, experiments will be performed to address the mechanism of transformation by vRel. First, we will characterize the mechanism by which vRel represses the c-rel promoter and activates Sp1 site-containing promoters. Second, we will characterize sequences in vRel that are necessary for its transforming activity, and the changes that can occur to make cRel transforming. After creating conditional mutants of vRel, we will attempt to identify genes controlled directly by vRel. The experiments proposed here will have relevance to gene control, oncogenesis, development, perhaps the control of HIV replication, and are meant to extend and expand ongoing studies in the laboratory aimed at understanding the mechanism of action of Rel proteins.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA047763-06
Application #
3191543
Study Section
Pathology B Study Section (PTHB)
Project Start
1988-09-01
Project End
1997-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
6
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Boston University
Department
Type
Schools of Arts and Sciences
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Haery, Leila; Mussakhan, Sultan; Waxman, David J et al. (2016) Evidence for an oncogenic modifier role for mutant histone acetyltransferases in diffuse large B-cell lymphoma. Leuk Lymphoma 57:2661-71
Gilmore, Thomas D; Gélinas, Céline (2015) Methods for assessing the in vitro transforming activity of NF-?B transcription factor c-Rel and related proteins. Methods Mol Biol 1280:427-46
Haery, Leila; Lugo-Picó, Julián G; Henry, Ryan A et al. (2014) Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth. Mol Cancer 13:29
Thompson, Ryan C; Vardinogiannis, Iosif; Gilmore, Thomas D (2013) Identification of an NF-?B p50/p65-responsive site in the human MIR155HG promoter. BMC Mol Biol 14:24
Thompson, Ryan C; Vardinogiannis, Iosif; Gilmore, Thomas D (2013) The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity. PLoS One 8:e62822
Yeo, Alan T; Porco Jr, John A; Gilmore, Thomas D (2012) Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis. Cancer Lett 318:53-60
Wolenski, Francis S; Chandani, Sushil; Stefanik, Derek J et al. (2011) Two polymorphic residues account for the differences in DNA binding and transcriptional activation by NF-?B proteins encoded by naturally occurring alleles in Nematostella vectensis. J Mol Evol 73:325-36
Wolenski, Francis S; Garbati, Michael R; Lubinski, Tristan J et al. (2011) Characterization of the core elements of the NF-?B signaling pathway of the sea anemone Nematostella vectensis. Mol Cell Biol 31:1076-87
Garbati, Michael R; Thompson, Ryan C; Haery, Leila et al. (2011) A rearranged EP300 gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity. Cancer Lett 302:76-83
Gilmore, Thomas D; Garbati, Michael R (2011) Inhibition of NF-?B signaling as a strategy in disease therapy. Curr Top Microbiol Immunol 349:245-63

Showing the most recent 10 out of 19 publications